D.E. Shaw & Co’s 2seventy bio TSVT Stock Holding History

D.E. Shaw & Co’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,200	Closed	-$338K	–	5943
2021 Q4	$338K	Buy	+13,200	New	+$412K	﹤0.01%	4626

Other funds holding TSVT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

D.E. Shaw & Co's TSVT Position: Q4 2022 in Review

D.E. Shaw & Co sold out of 2seventy bio (TSVT) in Q4 2022, closing a stake of 16,866 shares — an estimated $245K sold.

D.E. Shaw & Co first reported a position in TSVT in Q3 2022 and held it in 1 quarter. The position peaked at $245K in Q3 2022. 141 funds tracked by Wall St. Rank hold TSVT as of Q4 2022.

D.E. Shaw & Co reported no remaining 2seventy bio position as of Q4 2022 after selling out during the quarter.
D.E. Shaw & Co sold 16,866 2seventy bio shares in Q4 2022, an estimated $245K.
D.E. Shaw & Co first reported a position in 2seventy bio in Q3 2022 and held it in 1 quarter.
D.E. Shaw & Co's 2seventy bio position peaked at $245K in Q3 2022.
141 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.